Simpson Thacher Represents Initial Purchasers in $1 Billion Notes Offering by Roche
11.19.15
This is only gets display when printing
The Firm recently represented Barclays Capital Inc., BNP Paribas and UBS Securities LLC as joint bookrunners for an offering by Roche Holdings, Inc. of $1 billion aggregate principal amount of 3% notes due 2025, which are guaranteed by Roche Holding Ltd. The offering was conducted in reliance upon Rule 144A and Regulation S under the Securities Act of 1933. The proceeds of the offering were used for general corporate purposes.
The Roche Group is a leading international research-focused healthcare group which operates in more than 150 countries. Based on 2014 sales, the Roche Group was among the world’s largest producers of pharmaceuticals and was the world’s leading supplier of in vitro diagnostics.
The Simpson Thacher team for the offering included Mark Brod, Rohan Kaul and Michael Chao (Capital Markets); Christopher James (Intellectual Property); Taylor Alexander (Tax); Michael Isby (Environmental); and Jennie Getsin (Blue Sky).